Mass spectrometry (MS)-based omics technologies are now widely used to profile small
molecules in multiple matrices to confer comprehensive snapshots of cellular metabolic …

Metabolic syndrome (MetS) is a cluster of metabolic risk factors for diabetes, coronary heart
disease, non-alcoholic fatty liver disease, and some tumors. It includes insulin resistance …

Abstract n-3 polyunsaturated fatty acids (PUFA) have shown to exert beneficial effects in the
treatment of nonalcoholic fatty liver disease (NAFLD). Supplements of n-3 PUFA occur in …

Aims Adaptive immunity contributes to the pathogenesis of cardiovascular metabolic
disorders (CVMD). The omega-3 polyunsaturated fatty acids (n-3PUFA) are beneficial for …

Ceramides are bioactive lipids that act as secondary messengers for both intra-and inter-
cellular signaling. Elevated plasma concentrations of ceramides are associated with multiple …

Human milk is recommended for feeding preterm infants. The current pilot study aims to
determine whether breast-milk lipidome had any impact on the early growth-pattern of …

Fibrates and omega‐3 polyunsaturated acids are used for the treatment of
hypertriglyceridemia but have not demonstrated consistent effects on cardiovascular (CV) …

Background: Cannabigerol (CBG), a non-psychotropic phytocannabinoid found in Cannabis
sativa plants, has been the focus of recent studies due to its potential therapeutic properties …

Sphingolipids, in particular ceramides, play vital role in pathophysiological processes linked
to metabolic syndrome, with implications in the development of insulin resistance, pancreatic …

Non-alcoholic fatty liver disease (NAFLD) is a major clinical concern and its treatment
consumes abundant resources. While accumulation of lipids in hepatocytes initiates the …